All In Biotech

Drug Trial Radar · NCT03715166

Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder

A 6-month Randomised, Double-blind, Placebo Controlled Multicentre Parallel Group Study to Evaluate Efficacy and Safety of Bumetanide 0.5mg Twice a Day Followed by an Open Label Active 6-month Treatment Period With Bumetanide (0.5mg Twice a Day) and a 6 Weeks Discontinuation Period After Treatment Stop.

Last checked: Nov 20, 2026Latest source record: Jul 25, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. Randomized with 211 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

211

Actual

Start

Sep 24, 2018

Primary completion

Sep 13, 2021

Study completion Sep 13, 2021

Sponsor

Lead sponsor
Institut de Recherches Internationales ServierAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
ADIR, a Servier Group company
First posted
Oct 23, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 7 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study was to evaluate the efficacy and the safety of bumetanide/S95008 in the improvement of Autism Spectrum Disorder core symptoms.

Conditions

  • Autism Spectrum Disorder (ASD)

Interventions

  • Bumetanide Oral SolutionDrug

    Oral Solution dosed at 0.5mg/mL Taken twice daily

  • PlaceboDrug

    Oral Solution Taken twice daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Childhood Autism Rating Scale, Second Edition (CARS2) total raw scoreTime frame: Change from baseline to 6 month

Locations

45 sites in 10 countries. Site status is shown where the registry gives one.

  • Trial Tech em Pesquisas com Medicamentos Ltda

    Curitiba, Brazil

  • Hospital Universitário Walter Cantídio - Universidade Federal do Ceará

    Fortaleza, Brazil

  • Hospital São Vicente de Paulo

    Passo Fundo, Brazil

  • Universidade Federal de São Paulo, Escola Paulista de Medicina

    São Paulo, Brazil

  • Faculdade de Medicina da Universidade de São Paulo - Departamento de Psiquiatria

    São Paulo, Brazil

  • GSC CHU-LENVAL Centre ressource autisme

    Nice, Alpes-Maritimes, France

  • Centre d'Investigation Clinique de Lyon

    Bron, Auvergne-Rhône-Alpes, France

  • Hôpital Le Vinatier CRA Rhône-Alpes, Bat 211

    Bron, Auvergne-Rhône-Alpes, France

  • Hôpitaux Universitaires de Strasbourg Service de Psychiatrie de l'Enfant et de l'Adolescent

    Strasbourg, Grand Est, France

  • Hôpital Robert Debré Service de Psychiatrie de l'enfant et de l'adolescent

    Paris, Il de France, France

  • Centre Hospitalier Charles Perrens CRA Aquitaine

    Bordeaux, New Aquitaine, France

  • Hôpital des Enfants-Pellegrin

    Bordeaux, New Aquitaine, France

  • CHU Rouen

    Rouen, Normandy, France

  • Centre Hospitalier du Rouvray Centre de Ressources pour l'Autisme

    Sotteville-lès-Rouen, Normandy, France

  • Universitätsklinikum Freiburg, Zentrum für Psychische Erkrankungen, Klinik für Psychiatrie, Psychotherapie und Psychosomatik im Kindes- und Jugendalter

    Freiburg im Breisgau, Baden-Wurttemberg, Germany

  • Klinik für Psychiatrie und Psychotherapie des Kindes- und Jugendalters am Zentralinstitut für Seelische Gesundheit

    Mannheim, Baden-Wurttemberg, Germany

  • Universitätsklinikum Carl Gustav Carus an der TU Dresden, Klinik und Poliklinik für Kinder- und Jugendpsychiatrie und

    Dresden, Saxony (Sachsen), Germany

  • Vadaskert Korhaz es Szakambulancia

    Budapest, Hungary

  • Servus Salvus Kft.

    Budapest, Hungary

  • Bekes Megyei Kozponti Korhaz Gyermek es ifjusagpszichiatriai osztaly

    Gyula, Hungary

  • Szegedi Tudományegyetem Szent-Gyorgy Albert Klinikai Kozpont Gyermekgyógyászati Klinika Gyermek es Ifjusagpszichiátriai o

    Szeged, Hungary

  • Unità Semplice di Psichiatria Infantile Policlinico Universitario di Napoli - Università Federico II

    Naples, Campania, Italy

  • Neuro Riabilitazione/Psicopatologia dell'età evolutiva Istituto Scientifico Medea - Bosisio Parini

    Bosisio Parini, Lombardy, Italy

  • U.O. di Neuropsichiatria Infantile Fondazione Istituto Neurologico Nazionale Casimiro Mondino Istituto di Ricovero e Cura a Carattere Scientifico

    Pavia, Lombardy, Italy

  • Clinica di Neuropsichiatria dell'Infanzia e dell'Adolescenza Ospedale Pediatrico-Microcitemico

    Cagliari, Sardinia, Italy

  • Programma Interdipartimentale "Autismo 0-90" A.O.U. Policlinico "Gaetano Martino"

    Messina, Sicily, Italy

  • U.O.C. Psichiatria dello Sviluppo IRCCS Fondazione Stella Maris

    Calambrone, Tuscany, Italy

  • U.O. di Neuropsichiatria Infantile Azienda Ospedaliera Universitaria Senese

    Siena, Tuscany, Italy

  • Accare Groningen

    Groningen, Netherlands

  • Centrum Badań Klinicznych PI-House sp. z o.o

    Gdansk, Poland

  • Fundacja SYNAPSIS ul.

    Warsaw, Poland

  • NAVICULA Centrum Diagnozy i Terapii Autyzmu w Łodzi

    Lodz, Łódź Voivodeship, Poland

  • Samodzielny Publiczny Dziecięcy Szpital Kliniczny w Warszawie Oddział Kliniczny Psychiatrii Wieku Rozwojowego

    Warsaw, Masovian Voivodeship, Poland

  • Niepubliczny Zakład Opieki Zdrowotnej Gdańskie Centrum Zdrowia Sp. z o.o.

    Gdansk, Pomeranian Voivodeship, Poland

  • Centro Hospitalar e Universitario de Coimbra Hospital Pediatrico

    Coimbra, Portugal

  • Hospital General Universitario de Alicante

    Alicante, Spain

  • Hospital Clinic de Barcelona

    Barcelona, Spain

  • Hospital Niño Jesus

    Madrid, Spain

  • Hospital Universitario Gregorio Marañon

    Madrid, Spain

  • Hospita Mutua de Terrassa

    Terrassa, Barcelona, Spain

Showing 40 of 45 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.